alexa Enhanced Anti-proliferative And Pro-apoptotic Activities Of A Novel Curcumin-related Compound In Jurkat T-cells
ISSN: 2161-0444

Medicinal chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Burkhard Kloesch, Katrin Goldhahn, Lukas Gober, Michael Hintersteininger, Guenter Steiner and Thomas Erker
Accepted Abstracts: Med Chem
DOI: 10.4172/2161-0444.S1.013
Background: Curcumin is a naturally occurring polyphenol produced in the rhizome of Curcuma longa. The positive health effects of Curcumin (anti-inflammatory, anti-carcinogenic and antioxidative properties) have widely been studied. Inhibition of arachidonic acid metabolism by curcumin has been suggested to be a key mechanism for its anti-carcinogenic action. Recently, we reported about the synthesis of 7 novel curcumin analogues and their evaluation as selective COX-1 inhibitors. Compound 3 (HP102) was selected to evaluate its possible anti-carcinogenic features in Jurkat T-cells. Materials and Methods: Jurkat T-cells were stimulated with PMA/PHA in the absence or presence of different concentrations of HP102. IL-2 promoter activity and IL-2 release was analyzed by a luciferase reporter assay and ELISA, respectively. The effect of HP102 on cell viability, proliferation and apoptosis were monitored by XTT-assay, Annexin-V/7-AAD staining and Western blot. Results: Data showed that HP102 effectively blocked IL-2 expression in Jurkat cells in a dose-dependent manner. Compared to Curcumin, HP102 was about 10 times more effective in inhibition of IL-2 synthesis. Enhanced effects of HP102 towards Curcumin were also observed by monitoring cell viability, proliferation and apoptosis. Conclusion: The Curcumin analogue HP102 strongly improved the anti-proliferative and pro-apoptotic potential of the natural occurring Curcumin in Jurkat T-cells and might be a useful tool for the supportive care in T-cell leukemia in the future.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version